Imigran Tablets (Sumatriptan)

Description Sumatriptan IMIGRAN/IMITREX is a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for acute treatment of migraine with or without aura in adults. Imigran is indicated for the acute intermittent treatment of migraine. It should not be used prophylactically. The recommended dose of Imigran should not be exceeded. It is advisable that Imigran be given as early as possible after the onset of migraine attack but it is equally effective at whatever stage of the attack it is administered. The recommended dose of oral Imigran is a 50mg tablet. Some patients may require 100mg. If the patient has responded to the first dose but the symptoms recur a second dose may be given provided that there is a minimum interval of two hours between the two doses. No more than 300mg should be taken in any 24 hour period. Patients who do not respond to the prescribed dose of Imigran should not take a second dose for the same attack. In these cases the attack can be treated with paracetamol, acetylsalicylic acid, or non-steroidal anti-inflammatory drugs. Imigran may be taken for subsequent attacks. Imigran is recommended as monotherapy for the acute treatment of migraine and should not be given concomitantly with ergotamine or derivatives of ergotamine Limitations of Use: • Use only if a clear diagnosis of migraine headache has been established. • Not indicated for the prophylactic therapy of migraine attacks. • Not indicated for the treatment of cluster headache.